nodes	percent_of_prediction	percent_of_DWPC	metapath
Olsalazine—Aminosalicylic Acids—Sulfasalazine—ankylosing spondylitis	0.333	1	CiPCiCtD
Olsalazine—Sulfasalazine—ankylosing spondylitis	0.247	1	CrCtD
Olsalazine—ulcerative colitis—ankylosing spondylitis	0.184	1	CtDrD
Olsalazine—Balsalazide—Sulfasalazine—ankylosing spondylitis	0.107	1	CrCrCtD
Olsalazine—ALOX5—Sulfasalazine—ankylosing spondylitis	0.0365	0.332	CbGbCtD
Olsalazine—PPARG—Sulfasalazine—ankylosing spondylitis	0.0325	0.296	CbGbCtD
Olsalazine—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0097	0.0884	CbGbCtD
Olsalazine—PTGS2—Triamcinolone—ankylosing spondylitis	0.0097	0.0884	CbGbCtD
Olsalazine—PTGS2—Betamethasone—ankylosing spondylitis	0.00832	0.0759	CbGbCtD
Olsalazine—PTGS1—Sulfasalazine—ankylosing spondylitis	0.00819	0.0747	CbGbCtD
Olsalazine—PTGS2—Dexamethasone—ankylosing spondylitis	0.00484	0.0441	CbGbCtD
Olsalazine—IFNG—synovial membrane of synovial joint—ankylosing spondylitis	0.00224	0.505	CbGeAlD
Olsalazine—IFNG—IL23-mediated signaling events—IL23R—ankylosing spondylitis	0.000958	0.0644	CbGpPWpGaD
Olsalazine—IFNG—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.000724	0.0487	CbGpPWpGaD
Olsalazine—PTGS2—skeletal joint—ankylosing spondylitis	0.000575	0.13	CbGeAlD
Olsalazine—IFNG—Inflammatory Response Pathway—TNFRSF1B—ankylosing spondylitis	0.000506	0.034	CbGpPWpGaD
Olsalazine—IFNG—IL27-mediated signaling events—IL17A—ankylosing spondylitis	0.000506	0.034	CbGpPWpGaD
Olsalazine—IFNG—IL27-mediated signaling events—IL12B—ankylosing spondylitis	0.00047	0.0316	CbGpPWpGaD
Olsalazine—IFNG—Cytokines and Inflammatory Response—IL12B—ankylosing spondylitis	0.000456	0.0307	CbGpPWpGaD
Olsalazine—PTGS2—synovial membrane of synovial joint—ankylosing spondylitis	0.000437	0.0984	CbGeAlD
Olsalazine—IFNG—Hypertrophy Model—IL1A—ankylosing spondylitis	0.000427	0.0287	CbGpPWpGaD
Olsalazine—IFNG—TGF-beta Receptor Signaling—RUNX3—ankylosing spondylitis	0.000388	0.0261	CbGpPWpGaD
Olsalazine—PTGS2—cartilage tissue—ankylosing spondylitis	0.000386	0.0871	CbGeAlD
Olsalazine—IFNG—IL23-mediated signaling events—IL17A—ankylosing spondylitis	0.000381	0.0256	CbGpPWpGaD
Olsalazine—IFNG—IL23-mediated signaling events—IL12B—ankylosing spondylitis	0.000355	0.0238	CbGpPWpGaD
Olsalazine—IFNG—tendon—ankylosing spondylitis	0.000339	0.0764	CbGeAlD
Olsalazine—IFNG—Cytokines and Inflammatory Response—IL1A—ankylosing spondylitis	0.000336	0.0225	CbGpPWpGaD
Olsalazine—IFNG—Cytokines and Inflammatory Response—IL10—ankylosing spondylitis	0.000334	0.0224	CbGpPWpGaD
Olsalazine—IFNG—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000315	0.0212	CbGpPWpGaD
Olsalazine—IFNG—Inflammatory Response Pathway—CD40LG—ankylosing spondylitis	0.000307	0.0206	CbGpPWpGaD
Olsalazine—IFNG—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000298	0.02	CbGpPWpGaD
Olsalazine—IFNG—Proteasome Degradation—HLA-C—ankylosing spondylitis	0.000276	0.0185	CbGpPWpGaD
Olsalazine—IFNG—Interferon gamma signaling—HLA-C—ankylosing spondylitis	0.000253	0.017	CbGpPWpGaD
Olsalazine—IFNG—Type II interferon signaling (IFNG)—HLA-B—ankylosing spondylitis	0.000247	0.0166	CbGpPWpGaD
Olsalazine—IFNG—IL12-mediated signaling events—IL12B—ankylosing spondylitis	0.000241	0.0162	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000227	0.0153	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—IL17A—ankylosing spondylitis	0.000208	0.014	CbGpPWpGaD
Olsalazine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000204	0.0137	CbGpPWpGaD
Olsalazine—TPMT—tendon—ankylosing spondylitis	0.000195	0.044	CbGeAlD
Olsalazine—IFNG—Allograft Rejection—IL12B—ankylosing spondylitis	0.000193	0.013	CbGpPWpGaD
Olsalazine—IFNG—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.000169	0.0113	CbGpPWpGaD
Olsalazine—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.000166	0.0111	CbGpPWpGaD
Olsalazine—IFNG—Proteasome Degradation—HLA-B—ankylosing spondylitis	0.000163	0.011	CbGpPWpGaD
Olsalazine—IFNG—AP-1 transcription factor network—IL10—ankylosing spondylitis	0.000156	0.0105	CbGpPWpGaD
Olsalazine—IFNG—IL12-mediated signaling events—HLA-A—ankylosing spondylitis	0.000155	0.0104	CbGpPWpGaD
Olsalazine—IFNG—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000152	0.0102	CbGpPWpGaD
Olsalazine—IFNG—Proteasome Degradation—HLA-A—ankylosing spondylitis	0.000151	0.0102	CbGpPWpGaD
Olsalazine—IFNG—Interferon gamma signaling—HLA-B—ankylosing spondylitis	0.00015	0.0101	CbGpPWpGaD
Olsalazine—IFNG—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000144	0.00967	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—IL1A—ankylosing spondylitis	0.000142	0.00955	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—IL10—ankylosing spondylitis	0.000141	0.0095	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000141	0.0095	CbGpPWpGaD
Olsalazine—IFNG—Interferon gamma signaling—HLA-A—ankylosing spondylitis	0.000139	0.00933	CbGpPWpGaD
Olsalazine—IFNG—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	0.000137	0.00922	CbGpPWpGaD
Olsalazine—IFNG—Folate Metabolism—CRP—ankylosing spondylitis	0.000137	0.00922	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000134	0.00903	CbGpPWpGaD
Olsalazine—PTGS1—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000134	0.00903	CbGpPWpGaD
Olsalazine—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.000131	0.00883	CbGpPWpGaD
Olsalazine—IFNG—IL27-mediated signaling events—TNF—ankylosing spondylitis	0.000131	0.00879	CbGpPWpGaD
Olsalazine—PPARG—tendon—ankylosing spondylitis	0.000129	0.0291	CbGeAlD
Olsalazine—IFNG—Cytokines and Inflammatory Response—TNF—ankylosing spondylitis	0.000127	0.00853	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000125	0.00837	CbGpPWpGaD
Olsalazine—IFNG—Interferon Signaling—HLA-C—ankylosing spondylitis	0.000124	0.00831	CbGpPWpGaD
Olsalazine—IFNG—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.000113	0.00761	CbGpPWpGaD
Olsalazine—IFNG—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000109	0.00732	CbGpPWpGaD
Olsalazine—PTGS2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000107	0.00717	CbGpPWpGaD
Olsalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000105	0.00707	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.000103	0.00693	CbGpPWpGaD
Olsalazine—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.0001	0.159	CbGdCrCtD
Olsalazine—IFNG—IL23-mediated signaling events—TNF—ankylosing spondylitis	9.87e-05	0.00663	CbGpPWpGaD
Olsalazine—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	9.84e-05	0.156	CbGdCrCtD
Olsalazine—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	9.84e-05	0.156	CbGdCrCtD
Olsalazine—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	9.62e-05	0.153	CbGdCrCtD
Olsalazine—ALOX5—Selenium Micronutrient Network—CRP—ankylosing spondylitis	9.09e-05	0.00611	CbGpPWpGaD
Olsalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	9.04e-05	0.00608	CbGpPWpGaD
Olsalazine—IFNG—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	8.29e-05	0.00557	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—TLR4—ankylosing spondylitis	8.26e-05	0.00555	CbGpPWpGaD
Olsalazine—IFNG—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	8.26e-05	0.00555	CbGpPWpGaD
Olsalazine—IFNG—Immune System—KIR3DL1—ankylosing spondylitis	8.18e-05	0.0055	CbGpPWpGaD
Olsalazine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	7.76e-05	0.00521	CbGpPWpGaD
Olsalazine—PPARG—Transcription factor regulation in adipogenesis—TNF—ankylosing spondylitis	7.72e-05	0.00519	CbGpPWpGaD
Olsalazine—IFNG—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	7.63e-05	0.00513	CbGpPWpGaD
Olsalazine—IFNG—Interferon Signaling—HLA-B—ankylosing spondylitis	7.32e-05	0.00492	CbGpPWpGaD
Olsalazine—IFNG—TGF-beta Receptor Signaling—TNF—ankylosing spondylitis	7.29e-05	0.0049	CbGpPWpGaD
Olsalazine—IFNG—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	7.18e-05	0.00482	CbGpPWpGaD
Olsalazine—PTGS1—tendon—ankylosing spondylitis	6.91e-05	0.0156	CbGeAlD
Olsalazine—IFNG—Interferon Signaling—HLA-A—ankylosing spondylitis	6.78e-05	0.00456	CbGpPWpGaD
Olsalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—ankylosing spondylitis	6.75e-05	0.00454	CbGpPWpGaD
Olsalazine—PTGS2—tendon—ankylosing spondylitis	6.61e-05	0.0149	CbGeAlD
Olsalazine—IFNG—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	6.21e-05	0.00417	CbGpPWpGaD
Olsalazine—IFNG—Folate Metabolism—TNF—ankylosing spondylitis	6.21e-05	0.00417	CbGpPWpGaD
Olsalazine—PTGS1—Overview of nanoparticle effects—TNF—ankylosing spondylitis	6.08e-05	0.00409	CbGpPWpGaD
Olsalazine—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	6.03e-05	0.0957	CbGdCrCtD
Olsalazine—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	5.94e-05	0.0942	CbGdCrCtD
Olsalazine—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	5.94e-05	0.0942	CbGdCrCtD
Olsalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	5.85e-05	0.00393	CbGpPWpGaD
Olsalazine—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	5.8e-05	0.0921	CbGdCrCtD
Olsalazine—IFNG—Allograft Rejection—TNF—ankylosing spondylitis	5.38e-05	0.00361	CbGpPWpGaD
Olsalazine—IFNG—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	5.17e-05	0.00347	CbGpPWpGaD
Olsalazine—IFNG—Immune System—IL1R2—ankylosing spondylitis	4.96e-05	0.00333	CbGpPWpGaD
Olsalazine—IFNG—Selenium Micronutrient Network—TNF—ankylosing spondylitis	4.93e-05	0.00332	CbGpPWpGaD
Olsalazine—IFNG—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	4.88e-05	0.00328	CbGpPWpGaD
Olsalazine—PTGS2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	4.83e-05	0.00324	CbGpPWpGaD
Olsalazine—IFNG—Immune System—ERAP1—ankylosing spondylitis	4.7e-05	0.00316	CbGpPWpGaD
Olsalazine—IFNG—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	4.53e-05	0.00304	CbGpPWpGaD
Olsalazine—IFNG—Immune System—CARD9—ankylosing spondylitis	4.3e-05	0.00289	CbGpPWpGaD
Olsalazine—ALOX5—Selenium Micronutrient Network—TNF—ankylosing spondylitis	4.11e-05	0.00276	CbGpPWpGaD
Olsalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	4e-05	0.00269	CbGpPWpGaD
Olsalazine—PTGS1—Selenium Micronutrient Network—CRP—ankylosing spondylitis	3.94e-05	0.00265	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—TNF—ankylosing spondylitis	3.9e-05	0.00262	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—B3GNT2—ankylosing spondylitis	3.6e-05	0.00242	CbGpPWpGaD
Olsalazine—PTGS2—Selenium Micronutrient Network—CRP—ankylosing spondylitis	3.13e-05	0.0021	CbGpPWpGaD
Olsalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—ankylosing spondylitis	3.06e-05	0.00205	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—IL1A—ankylosing spondylitis	2.96e-05	0.00199	CbGpPWpGaD
Olsalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—ankylosing spondylitis	2.83e-05	0.0019	CbGpPWpGaD
Olsalazine—IFNG—Immune System—HLA-C—ankylosing spondylitis	2.7e-05	0.00181	CbGpPWpGaD
Olsalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	2.38e-05	0.0016	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—TLR4—ankylosing spondylitis	2.37e-05	0.00159	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—B3GNT2—ankylosing spondylitis	2.35e-05	0.00158	CbGpPWpGaD
Olsalazine—IFNG—Immune System—IL1RN—ankylosing spondylitis	2.34e-05	0.00158	CbGpPWpGaD
Olsalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	2.23e-05	0.0015	CbGpPWpGaD
Olsalazine—IFNG—Immune System—CD79A—ankylosing spondylitis	2.06e-05	0.00138	CbGpPWpGaD
Olsalazine—PPARG—Adipogenesis—TNF—ankylosing spondylitis	1.86e-05	0.00125	CbGpPWpGaD
Olsalazine—PTGS1—Selenium Micronutrient Network—TNF—ankylosing spondylitis	1.78e-05	0.0012	CbGpPWpGaD
Olsalazine—IFNG—Immune System—IL1A—ankylosing spondylitis	1.69e-05	0.00113	CbGpPWpGaD
Olsalazine—IFNG—Immune System—CD40LG—ankylosing spondylitis	1.68e-05	0.00113	CbGpPWpGaD
Olsalazine—PTGS2—Disease—ANTXR2—ankylosing spondylitis	1.64e-05	0.0011	CbGpPWpGaD
Olsalazine—IFNG—Immune System—HLA-B—ankylosing spondylitis	1.6e-05	0.00107	CbGpPWpGaD
Olsalazine—IFNG—Immune System—HLA-A—ankylosing spondylitis	1.48e-05	0.000993	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—B3GNT2—ankylosing spondylitis	1.46e-05	0.00098	CbGpPWpGaD
Olsalazine—PTGS2—Selenium Micronutrient Network—TNF—ankylosing spondylitis	1.42e-05	0.000952	CbGpPWpGaD
Olsalazine—IFNG—Immune System—CRP—ankylosing spondylitis	1.41e-05	0.000948	CbGpPWpGaD
Olsalazine—IFNG—Immune System—TLR4—ankylosing spondylitis	1.35e-05	0.000909	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—TNF—ankylosing spondylitis	1.12e-05	0.000753	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—B3GNT2—ankylosing spondylitis	1.02e-05	0.000686	CbGpPWpGaD
Olsalazine—PTGS2—Disease—B3GNT2—ankylosing spondylitis	9.68e-06	0.00065	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—B3GNT2—ankylosing spondylitis	8.11e-06	0.000545	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	7.62e-06	0.000512	CbGpPWpGaD
Olsalazine—PPARG—Developmental Biology—TNF—ankylosing spondylitis	6.4e-06	0.00043	CbGpPWpGaD
Olsalazine—PTGS2—Disease—HLA-A—ankylosing spondylitis	3.92e-06	0.000263	CbGpPWpGaD
